Advertisement
U.S. markets closed

MiNK Therapeutics, Inc. (INKT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.90000.0000 (0.00%)
At close: 04:00PM EST
0.8957 -0.00 (-0.48%)
After hours: 08:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/24/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
31.76M37.96M72.29M64.26M88.18M
Enterprise Value
25.36M102.56M136.89M128.86M152.79M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
10.05N/AN/AN/A13.08
Enterprise Value/Revenue
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA
-1.01-19.84-21.76-22.19-19.46

Trading Information

Stock Price History

Beta (5Y Monthly) 0.03
52-Week Change 3-55.00%
S&P500 52-Week Change 327.79%
52 Week High 33.3400
52 Week Low 30.7500
50-Day Moving Average 30.9571
200-Day Moving Average 31.4006

Share Statistics

Avg Vol (3 month) 353.17k
Avg Vol (10 day) 341.92k
Shares Outstanding 534.52M
Implied Shares Outstanding 634.52M
Float 89.9M
% Held by Insiders 171.41%
% Held by Institutions 12.97%
Shares Short (Jan 31, 2024) 4189.42k
Short Ratio (Jan 31, 2024) 43.49
Short % of Float (Jan 31, 2024) 43.68%
Short % of Shares Outstanding (Jan 31, 2024) 40.55%
Shares Short (prior month Dec 29, 2023) 4178.04k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sep 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-96.68%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.12M
Net Income Avi to Common (ttm)-24.77M
Diluted EPS (ttm)-0.7300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.4M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.62
Book Value Per Share (mrq)-0.39

Cash Flow Statement

Operating Cash Flow (ttm)-17.16M
Levered Free Cash Flow (ttm)-20.23M